10 Hot Biotech Stocks Under $5 to Buy
On June 4, 2026, CNBC reported that global biopharma M&A is on track for its strongest year since the pre-pandemic peak seven years ago.
Nrx Pharmaceuticals Inc. (NRXP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 24,700 | $52,611 | -32% | 0% | |
| 2. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 19,876 | $42,335 | 0% | |
| 3. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 4. | Point72 Asset Management Steve Cohen | 0 | $0 | 0% | |
| 5. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.17 | 40,000 | $46,800.00 | 84,634 | 2024-12-17 | Filing | |
| $0.32 | 35,000 | $11,196.50 | 105,000 | 2023-08-30 | Filing | |
| $0.29 | 70,000 | $20,125.00 | 570,000 | 2023-08-30 | Filing | |
| $0.33 | 100,000 | $33,000.00 | 446,332 | 2023-08-23 | Filing | |
| $0.32 | 200,000 | $64,400.00 | 346,332 | 2023-08-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.00 | 400,000 | $400,000.00 | 12,899,997 | 2022-12-07 | Filing | |
| $1.50 | 8,441 | $12,700.33 | 9,634,793 | 2022-11-30 | Filing | |
| $1.50 | 13,730 | $20,651.29 | 9,643,234 | 2022-11-29 | Filing | |
| $1.05 | 33,018 | $34,744.84 | 9,656,964 | 2022-11-17 | Filing | |
| $1.02 | 133,719 | $136,393.38 | 9,689,982 | 2022-11-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,000,000 | $6,390,000 | 4.74% | |
| 2. | 1,160,184 | $2,471,192 | 0% | |
| 3. | 420,467 | $895,595 | 0.16% | |
| 4. | 397,431 | $846,530 | 0% | |
| 5. | 310,112 | $660,609 | 0% |
News See All
7 Best Rated Penny Stocks to Buy According to Wall Street Analysts
Penny stocks remain one of the most controversial corners of the market — capable of producing enormous gains, devastating losses, and endless debate among billionaire investors and hedge fund managers...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Q4 2025 Results Conference Call. [Operator Instructions] This call is being recorded on Tuesday, March 24, 2026.
9 Best Psychedelic Stocks to Buy in 2026
The AdvisorShares Psychedelics ETF, a fund that primarily invests in the psychedelic drugs sector, is up 31% over the past year. That almost doubles the S&P 500’s 16% gain over the same timeframe.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals' Q3 2025 Earnings Conference Call.
NRx Pharmaceuticals, Inc. (NRXP)’ NRX-100 Wins Expanded FDA Fast Track for Suicidal Depression
NRx Pharmaceuticals, Inc.
13 Best Psychedelic Stocks to Invest in Now
Unlike drugs such as cocaine or marijuana, psychedelics create an “alternate reality” by altering feelings, thoughts, and energy levels.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to NRx Pharmaceuticals Q2 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, August 20, 2025.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx Pharmaceuticals First Quarter 2025 Earnings Call. At this time, all lines are in a listen-only mode.
Hedge Fund Resource Center